Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

Conorkenny Aug. 6 at 9:57 PM

Pfizer Largest Insider Buys in History 🚨 2 Directors have each purchased $1 million worth of $PFE shares, the largest insider buys in Pfizer's history 🤯 👀 $CTM $AXTI $VKTX

1 · Reply

jackofalltrade Aug. 6 at 9:48 PM

$PFE Paid Post from Pfizer The modern era for lung cancer patients. https://www.nytimes.com/paidpost/pfizer/the-modern-era-for-lung-cancer-patients.html?cmp=256791864&sid=9194834&pid=442084232&dclid=CPLw74b6jJYDFeqMWgUdvmkATQ&gad_source=7&gad_campaignid=23632797981

0 · Reply

Willieberich Aug. 6 at 8:38 PM

$PFE holding till it hits 50$

2 · Reply

TICKERTUTOR Aug. 6 at 8:36 PM

$PFE $BNTX $MRNA THE TRUMP ADMINISTRATION IS WEIGHING AN ORDER ON AUTISM AND VACCINES

1 · Reply

Bach_A Aug. 6 at 8:33 PM

Gain Therapeutics (NASDAQ: $GANX ) has major upcoming catalysts centered on the clinical development of its lead allosteric small molecule candidate, rexaceract (GT-02287), targeted as a disease-modifying treatment for Parkinson’s disease. Following recent FDA clearance of its Investigational New Drug (IND) application, the company is advancing into mid-stage trials.Upcoming Pipeline MilestonesQ3 2026 (Initiation of Phase 2 Trial): Patient dosing is scheduled to begin for the placebo-controlled, dose-range-finding Phase 2 clinical trial of GT-02287 for Parkinson's disease across sites in the U.S., Australia, and Europe.Q4 2026 (Phase 1b Final Data): Final data readouts and biomarker updates from the ongoing extended Phase 1b clinical study of GT-02287 are anticipated, tracking longer-term safety, target engagement, and neurodegeneration markers. $ABBV $SNY $PFE $XBI

0 · Reply

framus_morrigan Aug. 6 at 8:33 PM

$PFE And one month later here we are ... about to face its weekly SMA200 again ... Weekly chart

0 · Reply

nimii Aug. 6 at 8:18 PM

$PFE 27 tomorrow

2 · Reply

EingeLTrade Aug. 6 at 8:05 PM

Two $PFE directors have each purchased $1M worth of shares, the largest insider buys in Pfizer's history 👀

2 · Reply

Micheal_Pothead Aug. 6 at 8:05 PM

$PFE Albert you see what happens when leadership BUYS shares?

0 · Reply

dom04 Aug. 6 at 7:47 PM

$PFE breather? Or keeping up?

0 · Reply

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 1 day ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Quarterly report: Q2 2026

2026-08-04T11:39:45.000Z - 2 days ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Aug 4, 2026, 7:24 AM EDT - 2 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 2 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 2 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

2026-08-04T10:52:17.000Z - 2 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Aug 4, 2026, 6:52 AM EDT - 2 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

2026-08-04T10:51:36.000Z - 2 days ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:50:31.000Z - 2 days ago

Pfizer announces expansion of productivity enhancement Initiatives

Aug 4, 2026, 6:45 AM EDT - 2 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 3, 2026, 8:10 AM EDT - 3 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Jul 30, 2026, 7:48 AM EDT - 7 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

2026-07-30T11:03:18.000Z - 7 days ago

Pfizer says LITFULO studies meet co-primary endpoints

Jul 30, 2026, 6:45 AM EDT - 7 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

2026-07-29T20:42:19.000Z - 8 days ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

BNTX

Jul 29, 2026, 4:30 PM EDT - 8 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 15 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

2026-07-22T20:40:37.000Z - 15 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi

Jul 22, 2026, 4:30 PM EDT - 15 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 16 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 21 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 27 days ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 5 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 5 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 6 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 6 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 6 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 6 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 6 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Conorkenny Aug. 6 at 9:57 PM

Pfizer Largest Insider Buys in History 🚨 2 Directors have each purchased $1 million worth of $PFE shares, the largest insider buys in Pfizer's history 🤯 👀 $CTM $AXTI $VKTX

1 · Reply

jackofalltrade Aug. 6 at 9:48 PM

0 · Reply

Willieberich Aug. 6 at 8:38 PM

$PFE holding till it hits 50$

2 · Reply

TICKERTUTOR Aug. 6 at 8:36 PM

$PFE $BNTX $MRNA THE TRUMP ADMINISTRATION IS WEIGHING AN ORDER ON AUTISM AND VACCINES

1 · Reply

Bach_A Aug. 6 at 8:33 PM

0 · Reply

framus_morrigan Aug. 6 at 8:33 PM

$PFE And one month later here we are ... about to face its weekly SMA200 again ... Weekly chart

0 · Reply

nimii Aug. 6 at 8:18 PM

$PFE 27 tomorrow

2 · Reply

EingeLTrade Aug. 6 at 8:05 PM

Two $PFE directors have each purchased $1M worth of shares, the largest insider buys in Pfizer's history 👀

2 · Reply

Micheal_Pothead Aug. 6 at 8:05 PM

$PFE Albert you see what happens when leadership BUYS shares?

0 · Reply

dom04 Aug. 6 at 7:47 PM

$PFE breather? Or keeping up?

0 · Reply

EmbraceVolatility Aug. 6 at 7:42 PM

$PFE 52 week high by EOY.

0 · Reply

Micheal_Pothead Aug. 6 at 7:39 PM

$PFE

1 · Reply

Wstb100 Aug. 6 at 7:17 PM

$PFE actually in the green for once.

0 · Reply

bikechain Aug. 6 at 6:50 PM

$PFE What do you suppose the two Directors see, who each bought about $1M (filed yesterday)?

3 · Reply

marketlimit Aug. 6 at 6:26 PM

$PFE $21 soon… then $19… they have nothing make nothing do nothing and nothing happens. lol

1 · Reply

Micheal_Pothead Aug. 6 at 6:23 PM

$PFE mom, our stock is broken

0 · Reply

AviRun2Moon Aug. 6 at 5:55 PM

$PFE its always a middle finger…

0 · Reply

TraderDaKing Aug. 6 at 4:49 PM

$ELTP $PFE $JNJ $MRNA $LLY Who is doing a deal with Elite?? SequestOx (ELI-200) is an investigational, abuse-deterrent opioid product developed by Elite Pharmaceuticals containing a combination of oxycodone hydrochloride and sequestered naltrexone for managing moderate to severe pain. How SequestOx WorksNormal Use: Taken orally as intended, the opioid agonist (oxycodone) releases for pain relief while the antagonist (naltrexone) stays locked inside and passes through the body unreleased.Tampering: If the capsule or beads are crushed, chewed, or dissolved, the naltrexone releases.Blockade: The released naltrexone blocks the euphoric high of oxycodone by binding to brain receptors, which deters recreational abuse. https://elitepharma.com/ Roaring Kitty?

0 · Reply

Brice149 Aug. 6 at 4:26 PM

$PFE Lots of good if you look for it. The 20 and the 200 day ma are both moving up. The 50 is bottoming and will start moving up next week. The 100 day ma is still in a down trend, but we are right at it today.

1 · Reply

HarryPopotter Aug. 6 at 4:07 PM

$PFE https://www.change.org/p/keep-hope-alive-approve-deramiocel-children-with-dmd-are-dying

1 · Reply

Brice149 Aug. 6 at 4:05 PM

$PFE Woould be great to close above 25.92. Would love higher but that would be above the 100 day average and 200 day average.

1 · Reply

Brice149 Aug. 6 at 4:00 PM

$PFE Sitting right at the 200 day m/a

1 · Reply

Market Cap	144.82B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.14
Forward PE	8.43
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	51,044,827
Avg Vol	43,589,973
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	100%
Beta	0.34
Analysts	Sell
Price Target	$28.70